Stockscreener 앱 받기
8.19
1.33%
-0.11
시장 영업 전:
8.01
-0.18
-2.20%
전일 마감가:
$8.30
열려 있는:
$8.02
하루 거래량:
1.48M
Relative Volume:
1.10
시가총액:
$696.68M
수익:
-
순이익/손실:
$-43.16M
주가수익비율:
-14.89
EPS:
-0.55
순현금흐름:
$-29.31M
1주 성능:
-6.08%
1개월 성능:
-2.62%
6개월 성능:
+46.38%
1년 성능:
+82.81%
1일 변동 폭
$7.79
$8.39
1주일 범위
$7.75
$8.85
52주 변동 폭
$3.25
$14.44
Anavex Life Sciences Corporation Stock (AVXL) Company Profile
명칭
Anavex Life Sciences Corporation
전화
844-689-3939
주소
630 5TH AVENUE, NEW YORK
AVXL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVXL
Anavex Life Sciences Corporation
|
8.19 | 696.68M | 0 | -43.16M | -29.31M | -0.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Anavex Life Sciences Corporation Stock (AVXL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-12-06 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-23 | 개시 | Berenberg | Buy |
| 2021-09-23 | 개시 | BTIG Research | Buy |
| 2020-12-16 | 재확인 | H.C. Wainwright | Buy |
| 2020-09-28 | 개시 | Ladenburg Thalmann | Buy |
| 2020-02-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-06-18 | 개시 | Janney | Buy |
| 2018-05-16 | 재개 | Maxim Group | Buy |
| 2018-03-08 | 개시 | ROTH Capital | Buy |
| 2018-02-13 | 재확인 | Maxim Group | Buy |
| 2017-09-29 | 재개 | Noble Financial | Buy |
| 2017-02-07 | 개시 | Noble Financial | Buy |
| 2016-03-29 | 개시 | FBR Capital | Outperform |
모두보기
Anavex Life Sciences Corporation 주식(AVXL)의 최신 뉴스
Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer's Disease - The Manila Times
Breakthrough: New Alzheimer's Drug Cuts Cognitive Decline Over 4 Years in Clinical Trial - Stock Titan
Class Action Filed Against Anavex Life Sciences Corporation (AVXL) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
Class Action Filed Against Anavex Life Sciences Corporation (AVXL)May 13, 2024 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
Investors who lost money on Anavex Life Sciences Corporation(AVXL) should contact Levi & Korsinsky about pending Class ActionAVXL - ACCESS Newswire
AVXL’s price-to-free cash flow ratio: What it means for investors - uspostnews.com
Commonwealth Equity Services LLC Buys 7,285 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Given “Buy” Rating at HC Wainwright - Defense World
Anavex Life Sciences to Present at the 24th Annual Needham Virtual Healthcare Conference - The Manila Times
Anavex Showcases Breakthrough CNS Therapies: CEO Details Pipeline at Major Healthcare Conference - Stock Titan
Heartland Advisors Inc. Takes Position in Anavex Life Sciences Corp. (NASDAQ:AVXL) - MarketBeat
19,558 Shares in Anavex Life Sciences Corp. (NASDAQ:AVXL) Acquired by Proficio Capital Partners LLC - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Trading Down 3.2%Here's Why - MarketBeat
AVXL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Anavex Life Sciences Corp. Investors Can Join the Class Action Lawsuit! - ACCESS Newswire
Charles Schwab Investment Management Inc. Purchases 11,239 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Bank of New York Mellon Corp Has $2.37 Million Stock Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors With Losses to Inquire About Securities Class Action Investigation – AVXL - Business Wire
Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Acquired by Atria Investments Inc - Defense World
Proficio Capital Partners LLC Purchases New Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Did Anavex Life Sciences Corp. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- AVXL - ACCESS Newswire
Anavex Life Sciences Corp. to Host Earnings Call - ACCESS Newswire
Anavex Life Sciences Corp. (NASDAQ:AVXL) Stake Raised by Rhumbline Advisers - Defense World
Private Advisor Group LLC Sells 17,488 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
IMMINENT AVXL DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Anavex Life Sciences Corp. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Y Intercept Hong Kong Ltd Makes New $243,000 Investment in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences Corporation Sued for Securities Law ViolationsContact Levi & Korsinsky Before May 13, 2024 to Discuss Your RightsAVXL - ACCESS Newswire
Levi & Korsinsky Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 – AVXL - ACCESS Newswire
Levi & Korsinsky Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming DeadlineAVXL - ACCESS Newswire
27,052 Shares in Anavex Life Sciences Corp. (NASDAQ:AVXL) Bought by Atria Wealth Solutions Inc. - Defense World
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders - ACCESS Newswire
AVXL LAWSUIT ALERT: Levi & Korsinsky Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
D.A. Davidson & CO. Buys Shares of 11,385 Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Contrasting Cortexyme (NASDAQ:CRTX) and Anavex Life Sciences (NASDAQ:AVXL) - Defense World
Anavex Life Sciences Corp. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - ACCESS Newswire
Anavex Life Sciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 13, 2024 to Discuss Your RightsAVXL - ACCESS Newswire
Anavex Life Sciences Corp. (NASDAQ:AVXL) Is Expected To Breakeven In The Near Future - Yahoo Finance
Levi & Korsinsky Reminds Anavex Life Sciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024AVXL - ACCESS Newswire
When Will Anavex Life Sciences Corp. (NASDAQ:AVXL) Breakeven? - Simply Wall St
Shareholders that lost money on Anavex Life Sciences Corporation (AVXL) should contact Levi & Korsinsky about pending Class ActionAVXL - ACCESS Newswire
Anavex Life Sciences to Present at the 45th Annual TD Cowen Health Care Conference - The Manila Times
Can Anavex's Neurology Pipeline Transform Alzheimer's Treatment? CEO Presents Latest Progress - StockTitan
Anavex Life Sciences (NASDAQ:AVXL) Earns Buy Rating from HC Wainwright - MarketBeat
Brokers Issue Forecasts for AVXL Q1 Earnings - Defense World
UPCOMING AVXL DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Anavex Life Sciences Corp. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
AVXL SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Anavex Life Sciences Corp. Investors Can Join the Class Action Lawsuit - ACCESS Newswire
Wainwright maintains $42 target on Anavex Life Sciences stock By Investing.com - Investing.com Nigeria
AVXL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Anavex Life Sciences Corp. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Lost Money on Anavex Life Sciences Corporation(AVXL)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Wainwright maintains $42 target on Anavex Life Sciences stock - Investing.com
Anavex Life Sciences Corporation (AVXL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.01%
자본화:
|
볼륨(24시간):